NewsBenzingaSenti Biosciences Enters Equity Commitment Letter With CPIF II-9 On Nov 9, 2026; CPIF II-9 To Purchase Up To $4.55M Of Senti Biosciences Common Stock Senti Biosciences Enters Equity Commitment Letter With CPIF II-9 On Nov 9, 2026; CPIF II-9 To Purchase Up To $4.55M Of Senti Biosciences Common Stock Benzinga 2026.11.10 22:03 (GMT+0) Open on Benzinga Other news IBM Stock Moves Lower: What's Going On? JP Morgan Maintains Overweight on Itau Unibanco Holding, Lowers Price Target to $9 Amazon’s Big Week: First a New James Bond, Then Anthropic’s IPO JP Morgan Maintains Overweight on Allstate, Lowers Price Target to $291 TELUS Shares Rise After Québecor Submits Unsolicited Acquisition Proposal NVIDIA's Leadership Vacuum Hands AMD Its Biggest Opportunity in Years: Analysts